Advertisement
Advertisement

More Related Content

Advertisement
Advertisement

Class anterior pituitary hormones 15 th march 2014 2

  1. ANTERIOR PITUITARY HORMONES
  2.  Hormones are chemical substances which are synthesized by specific endogenous glands and secreted internally, directly into the blood stream, to act far away from the site of their production and release on the specific target organs. Ex- TSH  Tropic hormones-- target other endocrine glands to release their own hormones. Ex TRH
  3. 1. Hypophysiotropic hormones (Neuro-secretions) into the hypothalamo-hypophyseal portal system— 2. RH(Release Hormone) or RIH 3. Hypothalamic hormones travel in portal system from hypothalamus to anterior pituitary regulate hormones secretion by anterior pituitary
  4.  Master of endocrine orchestra  Regulated by Long and short loop feedback Hypothalamus RH(Release Hormone) or RIH  Primarily by the CNS– All pituitary hormones except PRL would decline in the absence of the hypothalamus  By hormones produced in peripheral target glands  Example– inhibin secreted from gonads  All anterior pituitary hormones secreted in a diurnal pattern.
  5. Short negetive feed back Long negetive feed back
  6.  Somatotrophs GH  Lactotrophs PRL  Gonadotrophs FSH growth of ovarian follicles and formation of sperm  Luteinizing hormone LH (in women)– induce ovulation and the formation of the corpus luteum; stimulate the ovarian production of estrogen and progesterone  LH (in men)– stimulates the production of Testosterone  Thyrotrophs  TSH to stimulate the secretion of thyroid hormone  Corticotrophs ACTH functions of adrenal cortex
  7. 1. 3. 2. hormonal families of the anterior lobe:
  8.  Protein synthesis  Anabolic effects  Somatomedins –IGF1, IGF2 Metabolic consequence   Initially insulin like effect   antagonistic to Insulin decrease glucose uptake, increase release of free fatty acids  IGF1-released from liver positive feedback on hypothalamus GHRIH  Increase-GH- sleep, exercise  Decrease-L-dopa
  9.  Hypo-secretion: During childhood causes Dwarfism  Hyper-secretion: During childhood causes Gigantism (up to 8 – 9 ft.) During Adulthood causes Acromegaly: Enlargement of the small bones of the hand and feet Enlargement of the cranium, nose, and lower jaw Tongue, liver, and kidneys become enlarged
  10.  Growth hormone releasing hormone (GHRH; from arcuate nuclei mainly); its gene is expressed in the GI tract and the pancreas  Somatostatin (Growth hormone release inhibiting hormone) (from preoptic periventricular and paraventricular nuclei); its gene is expressed in GI tract and the pancreas  Ghrelin (a peptide from the Arcuate Nuclei) also increase GH secretion via GHRH  Ghrelin is also synthesized in the stomach and is thought to signal feeding behavior
  11. SERMORELIN-Synthetic analogue of GnRH diagnostic agent suspect cases of childhood short stature ADR-injection site pain, dizziness, hyperactivity, urticaria SOMATOSTATIN-GHRIH SANDOSTATIN-slow release formulation ADR-steatorrrhoea, gall stones
  12. long acting analogue of somatostatin Twice potent in reducing insulin secretion Dose-20-200mg sc TDS Uses Carcinoid syndrome VIP-secreting tumours Bleeding oesophageal varices Treatment of AIDS associated diarrhoea Insulinomas Sandostatin –slow release formulation of octreotide
  13.  GHRIH  -thyroid tumours  Acromegaly PEGVISOMANT-sc  New GH-receptor antagonist-acromegaly  Suppress IGF-1 levels  -allows dimerisation and blocks the ongoing conformational changes  Demerit- formation of antibodies
  14. GH deficiency usually due to tumour, infection and radiation -t1/2-25 min Sc-0.2mg/kg AIDS Burn injuries Ant aging ADR-insulin resistance Arthralgia, DM-2
  15.  Recombinant human IGF1+ recombinant human IGFBP-3 ( insulin like growth factor inhibiting factor)  Maintain desired t1/2 of IGF  -short statured children  Dose-0.04-0.08 mg/kg  ADR-hypoglycemia
  16.  Glycoprotein hormone  Pulsatile secretion  TSH stimulate the thyroid to synthesise  thyroglobulin and thyroid hormones  Diagnostic purpose  Thyrotropin alpha- detection of metastatic differenciated thyroid cancer
  17. GnRH-gonadotropin release hormone LH-ICSH-Interstitial cell stimulating hormone FSH-inhibin- supresses FSH activin- stimulates FSH slynthesis FSH in females-gametogenesis, follicular devp LH in females-ovulation, corpus luteum FSH in males-spermatogensis, sertoli cells LH in males-androgen and testosterone in leydig cells Feed back Gonadorelin- synthetic
  18.  Leuprolide-endometriosis  Nafarelin  Buserelin-endometriosis  Dosrelin  Goserelin  Triptorelin- prostate cancer  Diagnosis and treatment of infertility  Anvanced prostate cancer, uterine fibroids  IVF-
  19. Cetrorelix Ganirelix Abarelix Degarelix Uses -advanced prostate ca Uterine fibroids and endometriosis IVF
  20. From post menopausal women Menotropin Urofollitropin Recombinant FSH HCG USES -infertility Cryptorchism IVF Kaposi sarcoma Diagnostic use
  21.  ACTH (adrenal corticotropic hormone) regulates hormone secretion by the cortex of the adrenal glands.  ACTH- stimulates –Glucocorticoids, mineralocorticoid and androgens  ACTH-stimulated by trauma and stress  Melanocytes and keratinocytes pigmentation by MSH  (Melanotrope in arcuate neurons)– food intake
  22.  Hypo-secretion Addison’s disease – Simmond’s disease, hypo pituitary cachexia Hyper-secretion: Cushing’s Syndrome mobilization of fat from lower body to the thoracic and upper abdominal regions giving raise to “Buffalo Torso”-obesity, poor wound healing, peptic ulcer, hyperglycemia
  23.  Is a synthetic human ACTH  Diagnosis of pituitary adrenal axis—25 IU-IV  No increase in plasma cortisol levels --primary  ADR- similar to corticosteroids  Allergic reactions
  24.  Peptide hormone  Mammotropic and lactogenic  PRIH-PRL release inhibitory hormone-D2  Stimulus for prolactin-suckling  mammotropic and lactogenic  Hyperprolactinemia-galactorrhoea, amenorrhea , infertility  Treatment of hyperprolactinaemia  Bromocriptine-2.5mg OD till BD for 15 days  , cabergoline, pergolide, Quinagolide
  25.  Bromocriptine -2.5mg orally-15days  Cabergoline-0.25mg orally -BD  Pergolide-  Quinagolide-0.2-0.6mg/day
  26.  OT (oxytocin) and ADH  produced in hypothalamus  transported by hypothalamo-hypophyseal tract to posterior lobe (stores/releases hormones)
  27. THANKYOU Download slides from Authorstream/presentations/raghuprasada Slideshare/presentations/raghuprasada Youtube/raghuprasada
Advertisement